ArticleFrontiers in pharmacology2024

A real-world pharmacovigilance study of polatuzumab vedotin based on the FDA adverse event reporting system (FAERS).

Dan Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.